Invion Ltd has released a press release.
General Meeting - Results of Meeting
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Invion
- Appendix 4C - December quarter
- Appendix 4C - September 2018 quarter
- New Photosoft formulation increased effect in ovarian cancer
- Spin out of respiratory assets for development in China
- Appendix 4E Annual Report and Full Year Statutory Accounts
Later from Invion
- Invion completes spin-out of respiratory assets
- Response to ASX Appendix 4C Query
- Appendix 4D and Financial Report for Half Year to 31 Dec 18
- Quarterly Update
- Animal studies show IVX-P02 potential in metastatic cancers
Follow Invion into a list and get an email when it puts out news.
Follow Invion